Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic is a research paper published in Obesity (2021). On theSindex it has a DataRank of 6.3. It has been cited 194 times, with 100 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.791
From this paper's citation signal
Citation Network Contribution
5.5
From 100 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: K23‐DK114460 (AA)
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: P30DK84567 (AA)
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: RO1‐DK67071 (MC)
Mayo Foundation for Medical Education and Research
Grant: CIM ‐ Career Development (AA)
NCATS NIH HHS
Grant: UL1 TR000135
NIDDK NIH HHS
Grant: K23 DK114460
NIDDK NIH HHS
Grant: R01 DK067071
NIDDK NIH HHS
Grant: R56 DK067071
NIDDK NIH HHS
Grant: P30 DK084567
National Institutes of Health
Grant: 5K23DK114460-04
Mechanisms of Enteroendocrine L-Cell Dysfunction and Bile Adaptations to Weight Loss
National Institutes of Health
Grant: 5P30DK084567-05
CLINICAL CORE
National Institutes of Health
Grant: 5UL1TR000135-08
Mayo Clinic Center for Clinical and Translational Science (CCaTS)
MeSH Terms
Keywords
Sustainable Development Goals